The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Identifieur interne : 001521 ( Main/Corpus ); précédent : 001520; suivant : 001522The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Auteurs : Zhihua Liu ; Jinwoo Lee ; Scott Krummey ; Wei Lu ; Huaibin Cai ; Michael J. LenardoSource :
- Nature Immunology [ 1529-2908 ] ; 2011-11.
Abstract
Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.
Url:
DOI: 10.1038/ni.2113
Links to Exploration step
ISTEX:57B1F26CFC85B06F61AAB005BED0CBAD41641054Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title><author><name sortKey="Liu, Zhihua" sort="Liu, Zhihua" uniqKey="Liu Z" first="Zhihua" last="Liu">Zhihua Liu</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lee, Jinwoo" sort="Lee, Jinwoo" uniqKey="Lee J" first="Jinwoo" last="Lee">Jinwoo Lee</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Krummey, Scott" sort="Krummey, Scott" uniqKey="Krummey S" first="Scott" last="Krummey">Scott Krummey</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lu, Wei" sort="Lu, Wei" uniqKey="Lu W" first="Wei" last="Lu">Wei Lu</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Cai, Huaibin" sort="Cai, Huaibin" uniqKey="Cai H" first="Huaibin" last="Cai">Huaibin Cai</name><affiliation><mods:affiliation>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lenardo, Michael J" sort="Lenardo, Michael J" uniqKey="Lenardo M" first="Michael J" last="Lenardo">Michael J. Lenardo</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: lenardo@nih.gov</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:57B1F26CFC85B06F61AAB005BED0CBAD41641054</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1038/ni.2113</idno><idno type="url">https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001521</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title><author><name sortKey="Liu, Zhihua" sort="Liu, Zhihua" uniqKey="Liu Z" first="Zhihua" last="Liu">Zhihua Liu</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lee, Jinwoo" sort="Lee, Jinwoo" uniqKey="Lee J" first="Jinwoo" last="Lee">Jinwoo Lee</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Krummey, Scott" sort="Krummey, Scott" uniqKey="Krummey S" first="Scott" last="Krummey">Scott Krummey</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lu, Wei" sort="Lu, Wei" uniqKey="Lu W" first="Wei" last="Lu">Wei Lu</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Cai, Huaibin" sort="Cai, Huaibin" uniqKey="Cai H" first="Huaibin" last="Cai">Huaibin Cai</name><affiliation><mods:affiliation>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation></author><author><name sortKey="Lenardo, Michael J" sort="Lenardo, Michael J" uniqKey="Lenardo M" first="Michael J" last="Lenardo">Michael J. Lenardo</name><affiliation><mods:affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: lenardo@nih.gov</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Nature Immunology</title><idno type="ISSN">1529-2908</idno><idno type="eISSN">1529-2916</idno><imprint><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher><date type="published" when="2011-11">2011-11</date><biblScope unit="volume">12</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1063">1063</biblScope><biblScope unit="page" to="1070">1070</biblScope></imprint><idno type="ISSN">1529-2908</idno></series><idno type="istex">57B1F26CFC85B06F61AAB005BED0CBAD41641054</idno><idno type="DOI">10.1038/ni.2113</idno><idno type="ArticleID">ni.2113</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1529-2908</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.</div></front></TEI><istex><corpusName>nature</corpusName><author><json:item><name>Zhihua Liu</name><affiliations><json:string>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</json:string></affiliations></json:item><json:item><name>Jinwoo Lee</name><affiliations><json:string>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</json:string></affiliations></json:item><json:item><name>Scott Krummey</name><affiliations><json:string>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</json:string></affiliations></json:item><json:item><name>Wei Lu</name><affiliations><json:string>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</json:string></affiliations></json:item><json:item><name>Huaibin Cai</name><affiliations><json:string>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA.</json:string></affiliations></json:item><json:item><name>Michael J Lenardo</name><affiliations><json:string>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</json:string><json:string>E-mail: lenardo@nih.gov</json:string></affiliations></json:item></author><language><json:string>eng</json:string></language><qualityIndicators><score>7.084</score><pdfVersion>1.4</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>928</abstractCharCount><pdfWordCount>7869</pdfWordCount><pdfCharCount>51126</pdfCharCount><pdfPageCount>9</pdfPageCount><abstractWordCount>132</abstractWordCount></qualityIndicators><title>The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title><genre><json:string>research-article</json:string></genre><host><volume>12</volume><pages><total>8</total><last>1070</last><first>1063</first></pages><issn><json:string>1529-2908</json:string></issn><issue>11</issue><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1529-2916</json:string></eissn><title>Nature Immunology</title></host><categories><wos><json:string>IMMUNOLOGY</json:string></wos></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1038/ni.2113</json:string></doi><id>57B1F26CFC85B06F61AAB005BED0CBAD41641054</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher><availability><p>NATURE</p></availability><date>2011</date></publicationStmt><notesStmt><note>Supplementary Text and Figures : Supplementary Figures 112 [ni.2113-S1]</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title><author><persName><forename type="first">Zhihua</forename><surname>Liu</surname></persName><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author><author><persName><forename type="first">Jinwoo</forename><surname>Lee</surname></persName><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author><author><persName><forename type="first">Scott</forename><surname>Krummey</surname></persName><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author><author><persName><forename type="first">Wei</forename><surname>Lu</surname></persName><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author><author><persName><forename type="first">Huaibin</forename><surname>Cai</surname></persName><affiliation>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author><author><persName><forename type="first">Michael J</forename><surname>Lenardo</surname></persName><email>lenardo@nih.gov</email><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation></author></analytic><monogr><title level="j">Nature Immunology</title><idno type="pISSN">1529-2908</idno><idno type="eISSN">1529-2916</idno><imprint><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher><date type="published" when="2011-11"></date><biblScope unit="volume">12</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1063">1063</biblScope><biblScope unit="page" to="1070">1070</biblScope></imprint></monogr><idno type="istex">57B1F26CFC85B06F61AAB005BED0CBAD41641054</idno><idno type="DOI">10.1038/ni.2113</idno><idno type="ArticleID">ni.2113</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.</p></abstract><abstract xml:lang="en" style="Editorial's summary"><p>The adaptor LRRK2 has been identified as a major susceptibility factor for Crohn's disease. Lenardo and colleagues show that LRRK2 negatively regulates activation of the transcription factor NFAT independently of NFAT phosphorylation.</p></abstract></profileDesc><revisionDesc><change when="2011-03-25">Received</change><change when="2011-08-19">Registration</change><change when="2011-11">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus nature" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0"</istex:xmlDeclaration><istex:docType PUBLIC="-//NPG//DTD XML Article//EN" URI="NPG_XML_Article.dtd" name="istex:docType"><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F1//EN" URL="ni.2113-F1" NDATA="ITEM" name="figf1"></istex:entity><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F2//EN" URL="ni.2113-F2" NDATA="ITEM" name="figf2"></istex:entity><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F3//EN" URL="ni.2113-F3" NDATA="ITEM" name="figf3"></istex:entity><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F4//EN" URL="ni.2113-F4" NDATA="ITEM" name="figf4"></istex:entity><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F5//EN" URL="ni.2113-F5" NDATA="ITEM" name="figf5"></istex:entity><istex:entity PUBLIC="-//NatureAmerica//FICI ni.2113-F6//EN" URL="ni.2113-F6" NDATA="ITEM" name="figf6"></istex:entity></istex:docType><istex:document><article id="ni.2113" language="eng" relation="no"><pubfm><jtl>Nature Immunology</jtl><vol>12</vol><iss>11</iss><idt>201111</idt><categ id="af"></categ><pp><spn>1063</spn><epn>1070</epn><cnt>8</cnt></pp><issn type="print">1529-2908</issn><issn type="electronic">1529-2916</issn><cpg><cpy>2011</cpy><cpn>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</cpn></cpg><suppinfo id="S1"><suppobj extrefid="ni.2113-S1" format="pdf" filesize="3M"><title>Supplementary Text and Figures</title><descrip><p>Supplementary Figures 1–12</p></descrip></suppobj></suppinfo><subject code="npg_subject_256"></subject><subject code="npg_subject_516"></subject><subject code="npg_subject_342"></subject><subject code="npg_subject_38"></subject><doi>10.1038/ni.2113</doi></pubfm><fm><atl>The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</atl><aug><au><fnm>Zhihua</fnm><snm>Liu</snm><inits>Z</inits><orf rid="a1"></orf></au><au><fnm>Jinwoo</fnm><snm>Lee</snm><inits>J</inits><orf rid="a1"></orf></au><au><fnm>Scott</fnm><snm>Krummey</snm><inits>S</inits><orf rid="a1"></orf></au><au><fnm>Wei</fnm><snm>Lu</snm><inits>W</inits><orf rid="a1"></orf></au><au><fnm>Huaibin</fnm><snm>Cai</snm><inits>H</inits><orf rid="a2"></orf></au><cau><fnm>Michael J</fnm><snm>Lenardo</snm><inits>M J</inits><orf rid="a1"></orf><corf rid="c1"></corf></cau><aff><oid id="a1"></oid><org>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health</org>, <cty>Bethesda</cty>, <st>Maryland</st>, <cny>USA</cny>.</aff><aff><oid id="a2"></oid><org>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health</org>, <cty>Bethesda</cty>, <st>Maryland</st>, <cny>USA</cny>.</aff><caff><coid id="c1"></coid><email>lenardo@nih.gov</email></caff></aug><hst><re year="2011" month="03" day="25"></re><acc year="2011" month="08" day="19"></acc><pubdate type="aop" year="2011" month="10" day="09"></pubdate></hst><edsumm type="standfirst" publish="aop"><title></title><p>The adaptor LRRK2 has been identified as a major susceptibility factor for Crohn's disease. Lenardo and colleagues show that LRRK2 negatively regulates activation of the transcription factor NFAT independently of NFAT phosphorylation.</p></edsumm><edsumm type="standfirst" publish="issue"><title></title><p>The adaptor LRRK2 has been identified as a major susceptibility factor for Crohn's disease. Lenardo and colleagues show that LRRK2 negatively regulates activation of the transcription factor NFAT independently of NFAT phosphorylation.</p></edsumm><abs><p>Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.</p></abs></fm></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="eng"><title>The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title></titleInfo><titleInfo type="alternative" lang="eng" contentType="CDATA"><title>The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease</title></titleInfo><name type="personal"><namePart type="given">Zhihua</namePart><namePart type="family">Liu</namePart><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jinwoo</namePart><namePart type="family">Lee</namePart><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Scott</namePart><namePart type="family">Krummey</namePart><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Wei</namePart><namePart type="family">Lu</namePart><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Huaibin</namePart><namePart type="family">Cai</namePart><affiliation>Unit of Transgenesis, Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael J</namePart><namePart type="family">Lenardo</namePart><affiliation>Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.</affiliation><affiliation>E-mail: lenardo@nih.gov</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Article"></genre><originInfo><publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher><dateIssued encoding="w3cdtf">2011-11</dateIssued><dateCaptured encoding="w3cdtf">2011-03-25</dateCaptured><dateValid encoding="w3cdtf">2011-08-19</dateValid><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="eng">Leucine-rich repeat kinase 2 (LRRK2) has been identified by genome-wide association studies as being encoded by a major susceptibility gene for Crohn's disease. Here we found that LRRK2 deficiency conferred enhanced susceptibility to experimental colitis in mice. Mechanistic studies showed that LRRK2 was a potent negative regulator of the transcription factor NFAT and was a component of a complex that included the large noncoding RNA NRON (an NFAT repressor). Furthermore, the risk-associated allele encoding LRRK2 Met2397 identified by a genome-wide association study for Crohn's disease resulted in less LRRK2 protein post-translationally. Severe colitis in LRRK2-deficient mice was associated with enhanced nuclear localization of NFAT1. Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.</abstract><abstract type="Editorial's summary" lang="eng">The adaptor LRRK2 has been identified as a major susceptibility factor for Crohn's disease. Lenardo and colleagues show that LRRK2 negatively regulates activation of the transcription factor NFAT independently of NFAT phosphorylation.</abstract><note type="additional physical form">Supplementary Text and Figures : Supplementary Figures 112 [ni.2113-S1]</note><relatedItem type="host"><titleInfo><title>Nature Immunology</title></titleInfo><classification displayLabel="npg_subject_256"></classification><classification displayLabel="npg_subject_516"></classification><classification displayLabel="npg_subject_342"></classification><classification displayLabel="npg_subject_38"></classification><identifier type="ISSN">1529-2908</identifier><identifier type="eISSN">1529-2916</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><detail type="issue"><caption>no.</caption><number>11</number></detail><extent unit="pages"><start>1063</start><end>1070</end><total>8</total></extent></part></relatedItem><identifier type="istex">57B1F26CFC85B06F61AAB005BED0CBAD41641054</identifier><identifier type="DOI">10.1038/ni.2113</identifier><identifier type="ArticleID">ni.2113</identifier><accessCondition type="use and reproduction" contentType="copyright">©2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</accessCondition><recordInfo><recordContentSource>NATURE</recordContentSource></recordInfo></mods></metadata><covers><json:item><original>true</original><mimetype>image/gif</mimetype><extension>gif</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/covers/gif</uri></json:item></covers><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/annexes/jpeg</uri></json:item><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/annexes/pdf</uri></json:item></annexes><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/57B1F26CFC85B06F61AAB005BED0CBAD41641054/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">IMMUNOLOGY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001521 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001521 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:57B1F26CFC85B06F61AAB005BED0CBAD41641054
|texte= The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
}}
| This area was generated with Dilib version V0.6.23. |  |